HCL Technologies köper C3i Solutions

Uppköpet ett steg i HCL:s satsning inom biovetenskap och konsumentprodukter 

Noida, India och Horsham, PA, 9:e april, 2018 – IT-konsultjätten HCL Technologies Limited (HCL), har köpt C3i Solutions av Merck & Co., Inc, vilka i Sverige är mest kända som MSD. C3i Solutions är ledande när det gäller kundvårdslösningar på marknaderna för biovetenskap och förpackade konsumentprodukter (CPG).

Genom uppköpet kompletterar HCL sina IT- och affärsutvecklingstjänster inom biovetenskap och konsumentproduktmarknaden med den djupa branschkompetens som C3i har. C3i:s expertis inom säljsupport och starka partnerskap med branschledande produktföretag kommer att ge HCL möjlighet att bli ännu bättre på att leverera biovetenskapsrelaterade tjänster med patienten i fokus och att erbjuda mer effektiva tjänster till IT- och affärspartners inom sjukvården. Uppköpet bygger vidare på ett mer än 13 års långt IT-partnerskap mellan HCL och Merck & Co., Inc., inklusive tjänster inom ramen för HCL:s  tjänstestrategi Mode 1-2-3.  

Partnerskapet bygger även vidare på HCL:s satsningar inom tjänster för att optimera kundvård- och kundengagemang, särskilt genom att implementera advanced analytics, IOT och digitalisering. Det C3i bidrar med kommer dessutom att bli allt viktigare i takt med att branschen blir mer digitaliserad och mer beroende av starka och individanpassade kundupplevelser.

-       C3i ger HCL innovativa och kompletterande tjänster och en omfattande kundbas som stärker HCL:s position som ledande IT-tjänsteleverantör ytterligare, säger C Vijayakumar, President och CEO, HCL Technologies.  Uppköpet kommer att hjälpa HCL:s kunder inom biovetenskapsbranschen att bli mer patientinriktade och att utveckla lösningar som adresserar den digitala revolution som präglar branschen. Vi tilltalades också av C3i ledning och anställda och vi önskar dem varmt välkomna till HCL.

-       HCL och C3i Solutions matchar varandra som företag genom att vi båda sätter kunden i centrum, säger Joel Morse, President, C3i Solutions. Det är också därför som vi anser att företagen är som gjorda för varandra. Förutom att HCL:s produkt- och tjänsteportföljer tilltalade oss, kommer vi och våra kunder att ha stor nytta av HCL:s djupa teknikkunskaper och innovativa arbetssätt. Det innebär att vi kan fortsätta att leverera supporttjänster av högsta kvalitet.

About C3i Solutions

C3i Solutions is multi-channel customer engagement services provider, specializing in global, high-touch consumer, patient, and end-user management . For the past 35 years, our unique, multi-channel approach and experience in highly regulated industries have made us the partner-of-choice for some of the world’s most trusted brands. With a strategic focus on innovation, we excel at protecting our clients’ brands, while maximizing productivity and cost efficiency. C3i Solutions, the business name of Telerx Marketing, Inc., is part of Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc., Kenilworth, New Jersey, USA (known as MSD outside the United States and Canada), is headquartered in Horsham, PA. For more information, visit www.c3isolutions.com.

About HCL Technologies

HCL Technologies (HCL) is a leading global IT services company that helps global enterprises re–imagine and transform their businesses through digital technology transformation. HCL operates out of 32 countries and has consolidated revenues of US$ 7.6 billion, for 12 Months ended 31st December 2017. HCL focuses on providing an integrated portfolio of services underlined by its Mode 1–2–3 growth strategy. Mode 1 encompasses the core services in the areas of Applications, Infrastructure, BPO and Engineering & R&D services, leveraging DRYiCETM Autonomics to transform clients' business and IT landscape, making them 'lean' and 'agile'. Mode 2 focuses on experience–centric and outcome–oriented integrated offerings of Digital & Analytics, IoT WoRKS™, Cloud Native Services and Cybersecurity & GRC services to drive business outcomes and enable enterprise digitalization. Mode 3 strategy is ecosystem–driven, creating innovative IP–partnerships to build products and platforms business.

HCL leverages its global network of integrated co-innovation labs and global delivery capabilities to provide holistic multi–service delivery in key industry verticals including Financial Services, Manufacturing, Telecommunications, Media, Publishing, Entertainment, Retail & CPG, Life Sciences & Healthcare, Oil & Gas, Energy & Utilities, Travel, Transportation & Logistics and Government. With 119,291 professionals from diverse nationalities, HCL focuses on creating real value for customers by taking 'Relationships Beyond the Contract'. For more information, please visit www.hcltech.com

Forward–looking Statements

Certain statements in this release are forward-looking statements, which involve a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those in such forward-looking statements. All statements, other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to the statements containing the words 'planned', 'expects', 'believes’,’ strategy', 'opportunity', 'anticipates', 'hopes' or other similar words. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding impact of pending regulatory proceedings, fluctuations in earnings, our ability to manage growth, intense competition in IT services, business process outsourcing and consulting services including those factors which may affect our cost advantage, wage increases in India, customer acceptances of our services, products and fee structures, our ability to attract and retain highly skilled professionals, our ability to integrate acquired assets in a cost-effective and timely manner, time and cost overruns on fixed-price, fixed-timeframe contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, the success of our brand development efforts, liability for damages on our service contracts, the success of the companies /entities in which we have made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property, other risks, uncertainties and general economic conditions affecting our industry. There can be no assurance that the forward-looking statements made herein will prove to be accurate, and issuance of such forward-looking statements should not be regarded as a representation by the Company, or any other person, that the objective and plans of the Company will be achieved. All forward-looking statements made herein are based on information presently available to the Management of the Company and the Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.

For details contact  

HCL Technologies

Elka Ghudial